期刊文献+

急性心肌梗死基层医院治疗219例分析 被引量:4

Analysis on treatment of 219 cases with acute myocardial infarction by primary hospital
下载PDF
导出
摘要 血管病是当今威胁生命和健康的主要疾病之一。心脏病及血管粥样硬化性疾病导致的死亡已超过了copd和肿瘤、意外伤害,成为首位死亡原因。患肌心梗死(心梗)的平均年龄比前提前,而传统的危险因素如高血压、血脂异常、2型糖尿病和吸烟等有较强的预测作用,心肌梗死的治疗现状与临床指南仍存在相当大的差距,特别是基层医院,如较多的县市级医院,由于各医院的发展及硬件的差异,急性心肌梗死的治疗相差较大。更多的基层医院采用传统的药物治疗加溶栓等,少数病人应用介入治疗。应用各种方法治疗,只要充分的和病人及家属沟通,让病人及家属采纳,充分尊重病人和家属的知情权,尊重病人和家属的选择权利,应该说都是合理的,临床治疗效果已较为满意。 Cardiovascular disease is one of the main diseases in today's threat to life and health.Heart disease and vascular atherosclerotic disease cause of death has exceeded the copd and tumor, accident harm, became the first cause of death.Than the average age of the risk of myocardial infarction (mi) in advance, and traditional risk factors such as hypertension, dyslipidemia, type 2 diabetes, and smoking have stronger prediction function, the treatment of myocardial infarction, present situation and the clinical guidelines there is still a considerable gap, especially the grass-roots hospitals and some theory guilds as more of a hospital, due to differences in the development of the hospital and hardware, the treatment of acute myocardial infarction (mi) is large.More basic-level hospitals, the use of the traditional drug treatment and thrombolysis guardianship, such as a few patient application of interventional therapy. Application of various methods of treatment, as long as sufficient communication with patients and their families, let the patient and family to adopt,fully respect for patients and family members' right to know, respect for patients and family members of the right to choose, it should be said is reasonable, has obtained satisfactory clinical effect.
机构地区 曲阜市中医院
出处 《中医临床研究》 2015年第6期46-48,共3页 Clinical Journal Of Chinese Medicine
关键词 心肌梗死 糖尿病 介入治疗 Myocardial infarction Diabetes Interventional therapy
  • 相关文献

参考文献2

二级参考文献6

  • 1Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS),European Association for Percutaneous Cardiovascular Interventions (EAPCI),Wijns W. Guidelines on myocardial revascularization[J].European Heart Journal,2010.2501-2555. 被引量:1
  • 2Levine GN,Bates ER,Blankenship JC. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions[J].Circulation,2011.e574-e651. 被引量:1
  • 3Hillis LD,Smith PK,Anderson JL. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.developed in collaboration with the American Association for Thoracic Surgery,Society of Cardiovascular Anesthesiologists,and Society of Thoracic Surgeons[J].Journal of the American College of Cardiology,2011.e123-e210. 被引量:1
  • 4Nashef SA,Roques F,Michel P. European system for cardiac operative risk evaluation (EuroSCORE)[J].European Journal of Cardio-Thoracic Surgery,1999.9-13. 被引量:1
  • 5Serruys PW,Morice MC,Kappetein AP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J].New England Journal of Medicine,2009.961-972. 被引量:1
  • 6Peterson ED,Dai D,DeLong ER. Contemporary mortality risk prediction for percutaneous coronary intervention:results from 588,398 procedures in the Natio Cardiovascular Data Registry[J].Journal of the American College of Cardiology,2010.1923-1932. 被引量:1

共引文献136

同被引文献24

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部